The continuum of growth hormone-IGF-I axis defects causing short stature: Diagnostic and therapeutic challenges

Clinical Endocrinology

Volumn 72, Issue 6, 2010, Pages 721-728

  Savage, Martin O ^a   Burren, Christine P ^b   Rosenfeld, Ron G ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; HUMAN GROWTH HORMONE;

CHILD GROWTH; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENDOCRINE FUNCTION TEST; GENE MUTATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW; SHORT STATURE; SOMATOMEDIN C DEFICIENCY; ADULT; ALGORITHM; BODY HEIGHT; ENDOCRINE SYSTEM EXAMINATION; GENETICS; GROWTH DISORDERS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ADULT; ALGORITHMS; BODY HEIGHT; DIAGNOSTIC TECHNIQUES, ENDOCRINE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 77952661532     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03775.x     Document Type: Review

References (70)

1. Rosenfeld, R.G. (2003) Insulin-like growth factors and the basis of growth. New England Journal of Medicine, 349, 2184 2186.
2. Salmon, W.D. Jr. Daughaday, W.H. (1957) A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine, 49, 825 836.
3. Green, H., Morikawa, M. Nixon, T. (1985) A dual effector theory of growth-hormone action. Differentiation, 29, 195 198.
4. Kaplan, S.A. Cohen, P. (2007) The somatomedin hypothesis 2007: 50 years later. Journal of Clinical Endocrinology & Metabolism, 92, 4529 4535.
5. Yakar, S., Liu, J.L., Stannard, B. et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proceedings of the National Academy of Sciences of the United States of America, 96, 7324 7329.
6. Ueki, I., Ooi, G.T., Tremblay, M.L. et al. (2000) Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proceedings of the National Academy of Sciences of the United States of America, 97, 6868 6873.
7. Domené, H.M., Bengolea, S.V., Martínez, A.S. et al. (2004) Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. New England Journal of Medicine, 350, 570 577.
8. Fowden, A.L. (2003) The insulin-like growth factors and feto-placental growth. Placenta, 24, 803 812.
9. Lupu, F., Terwilliger, J.D., Kaechoong, L. et al. (2001) Roles of growth hormone and insulin-like growth factor-1 in mouse postnatal growth. Developmental Biology, 229, 141 162.
10. Woods, K.A., Camacho-Hübner, C., Savage, M.O. et al. (1996) Intrauterine growth retardation and post-natal growth failure associated with deletion of the insulin-like growth factor-I gene. New England Journal of Medicine, 355, 1363 1367.
11. Walenkamp, M.J., van der Kamp, H.J., Pereira, A.M. et al. (2006) A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. Journal of Clinical Endocrinology & Metabolism, 91, 3062 3470.
12. Dattani, M.T. (2005) Growth hormone deficiency and combined pituitary growth hormone deficiency: does the genotype matter? Clinical Endocrinology (Oxford), 63, 121 130.
13. Rosenfeld, R.G., Rosenbloom, A.L. Guevara-Aguirre, J. (1994) Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews, 15, 369 390.
14. Cohen, P. (2006) Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders. Journal of Clinical Endocrinology & Metabolism, 91, 4235 4236.
15. Alatzoglou, K.S., Turton, J.P., Kelberman, D. et al. (2009) Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated GH deficiency. Journal of Clinical Endocrinology & Metabolism, 94, 3191 3199.
16. Ranke, M.B. Lindberg, A. (2009) Predicting growth in response to growth hormone treatment. Growth Hormone & IGF Research, 19, 1 11.
17. Wit, J.M., Clayton, P.E., Rogol, A.D. et al. (2008) Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone & IGF Research, 18, 89 110.
18. Attie, K.M., Carlsson, L.M., Rundle, A.C. et al. (1995) Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. Journal of Pediatrics, 127, 244 250.
19. Goddard, A.D., Dowd, P., Chernausek, S. et al. (1997) Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. Journal of Pediatrics 131, S51 S55.
20. Sanchez, J.E., Perera, E., Baumbach, L. et al. (1998) Growth hormone receptor mutations in children with idiopathic short stature. Journal of Clinical Endocrinology & Metabolism, 83, 4079 4083.
21. Savage, M.O., Attie, K.M., David, A. et al. (2006) Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nature Clinical Practice Endocrinology & Metabolism, 2, 395 407.
22. Guevara-Aguirre, J., Rosenbloom, A.L., Guevara-Aguirre, M. et al. (2007) Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3 and stature. Growth Hormone & IGF Research, 17, 261 264.
23. Park, P. Cohen, P. (2005) Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS). Growth Hormone & IGF Research, 15, S13 S20.
24. Wudy, S.A., Hagemann, S., Dempfle, A. et al. (2005) Children with idiopathic short stature are poor eaters and have decreased body mass index. Pediatrics, 116, e52 e57.
25. Rosenbloom, A.L. (2009) Idiopathic short stature: conundrums of definition and treatment. International Journal of Paediatric Endocrinology, Article ID 470378, 1 5.
26. Bright, G.M., Attie, K.M., Julius, J.R. et al. (2004) IGF-I deficiency: prevalence and clinical characteristics among short children. International Congress of Endocrinology, Lisbon, Abstract OR 84.
27. Van Meter, Q., Midyett, L.K., Deeb, L. et al. (2008) Prevalence of primary IGFD among untreated children with short stature in a prospective multi-centre study. International Congress of Endocrinology, Rio de Janeiro, Abstract POO715.
28. Burren, C.P., Woods, K.A., Rose, S.J. et al. (2001) Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome. Hormone Research, 55, 125 130.
29. Pilecka, I., Whatmore, A., Hooft van Huijsduijnen, R. et al. (2007) growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options. Trends in Endocrinology & Metabolism, 18, 12 18.
30. Diniz, E.T., Jorge, A.A., Arnhold, I.J. et al. (2008) Novel missense mutation (pY113X) in the human growth hormone receptor gene in a Brazilian patient with Laron syndrome. Arquivos Brasileiros de Endocrinologia & Metabologia 52, 1264 1271. [In Portuguese].
31. Woods, K.A., Dastot, F., Preece, M.A. et al. (1997) Phenotype: genotype relationships in growth hormone insensitivity syndrome. Journal of Clinical Endocrinology & Metabolism, 82, 3529 3535.
32. Rosenbloom, A.L., Guevara-Aguirre, J., Rosenfeld, R.G. et al. (1999) Growth hormone receptor deficiency in Ecuador. Journal of Clinical Endocrinology & Metabolism, 84, 4436 4443.
33. Metherell, L.A., Akker, S.A., Munroe, P.B. et al. (2001) Pseudoexon activation as a novel mechanism for disease resulting in atypical growth hormone insensitivity. American Journal of Human Genetics, 69, 641 646.
34. David, A., Camacho-Hübner, C., Bhangoo, A. et al. (2007) An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes. Journal of Clinical Endocrinology & Metabolism, 92, 655 659.
35. Ayling, R.M., Ross, R.J.M., Towner, P. et al. (1997) A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nature Genetics, 16, 13 14.
36. Kofoed, E.M., Hwa, V., Little, B. et al. (2003) Growth hormone insensitivity associated with a STAT5b mutation. New England Journal of Medicine, 349, 1139 1147.
37. Rosenfeld, R.G., Belgorosky, A., Camacho-Hübner, C. et al. (2007) Defects in growth hormone receptor signalling. Trends in Endocrinology & Metabolism, 18, 134 141.
38. Domené, H.M., Hwa, V., Argente, J. et al. (2009) Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Hormone Research 72, 129 141.
39. Fofanova-Gambetti, O.V., Hwa, V., Kirsch, S. et al. (2009) Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins. Hormone Research, 71, 100 110.
40. Abuzzahab, M.J., Schneider, A., Goddard, A. et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine, 349, 2211 2222.
41. Walenkamp, M.J., Karperien, M., Pereira, A.M. et al. (2005) Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. Journal of Clinical Endocrinology & Metabolism, 90, 2855 2864.
42. Netchine, I., Azzi, S., Houang, M. et al. (2009) Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. Journal of Clinical Endocrinology & Metabolism, 94, 3913 3921.
43. Walenkamp, M.J. Wit, J.M. (2008) Single gene mutations causing SGA. Best Practice Research Clinical Endocrinology & Metabolism, 22, 433 446.
44. Cohen, P., Rogol, A.D., Deal, C.L. et al. (2008) Consensus statement on the diagnosis and treatment of children with idiopathic short stature. A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology Workshop. Journal of Clinical Endocrinology & Metabolism, 93, 4210 4217.
45. GH Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology & Metabolism, 85, 3990 3993.
46. Cianfarani, S., Liguori, A., Boemi, S. et al. (2005) Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. Journal of Clinical Endocrinology & Metabolism, 90, 6028 6034.
47. Juul, A., Bang, P., Hertel, N.T. et al. (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. Journal of Clinical Endocrinology & Metabolism, 78, 744 752.
48. Juul, A., Dalgaard, P., Blum, W.F. et al. (1995) Serum levels of insulin-like growth factor (IGF)- binding protein- 3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation. Journal of Clinical Endocrinology & Metabolism, 80, 2534 2542.
49. Burren, C.P., Wanek, D., Mohan, S. et al. (1999) Serum levels of insulin-like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity. Acta Paediatrica Supplement, 88, 185 191.
50. Bjarnason, R., Banerjee, K., Rose, S.J. et al. (2002) Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity. Clinical Endocrinology (Oxford), 57, 357 361.
51. Rosenfeld, R.G., Kemp, S.F. Hintz, R.L. (1981) Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. Journal of Clinical Endocrinology & Metabolism, 53, 611 617.
52. Rosenfeld, R.G. (2005) The IGF system: new developments relevant to pediatric practice. In S. Cianfarani, D.R. Clemmons, M.O. Savage eds. IGF-I and IGF Binding Proteins: Basic Research and Clinical Management, Vol. 9. Endocrine Development. Karger
53. Blum, W.F., Cotterill, A.M., Postel-Vinay, M.C. et al. (1994) Improvement in diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Paediatrica Supplement, 399, 117 124.
54. Selva, K.A., Buckway, C.K., Sexton, G. et al. (2003) Reproducibility in patterns of IGF generation tests with special reference to idiopathic short stature. Hormone Research, 60, 237 246.
55. Bright, G.M. Frane, J. (2007) IGF-1 and IGFBP-3 responses to exogenous GH in prepubertal children with primary IGF-I deficiency. Endocrine Society Meeting, Abstract P2-510.
56. Buckway, C.K., Guevara-Aguirre, J., Pratt, K.L. et al. (2001) The IGF-I test revisited: a marker of GH sensitivity. Journal of Clinical Endocrinology & Metabolism, 86, 5176 5183.
57. Reiter, E.O., Price, D.A., Wilton, P. et al. (2006) Effect of growth hormone (GH) treatment on the near final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. Journal of Clinical Endocrinology & Metabolism, 91, 2047 2054.
58. Cutfield, W., Lindberg, A., Albertsson-Wikland, K. et al. (1999) Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatrica Supplement, 88, 72 75.
59. Bakker, B., Frane, J., Anhalt, H. et al. (2008) Height velocity targets from the National Cooperative Growth Study for first-year growth hormone responses in short children. Journal of Clinical Endocrinology & Metabolism, 93, 352 357.
60. Cohen, P., Bright, G.M., Rogol, A.D. et al. (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. Journal of Clinical Endocrinology & Metabolism, 87, 90 98.
61. Cohen, P., Rogol, A.D., Howard, C.P. et al. (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized controlled study. Journal of Clinical Endocrinology & Metabolism, 92, 2480 2486.
62. Wit, J.M., Reiter, E.O., Ross, J.L. et al. (2008) Idiopathic short stature: management and growth hormone treatment. Growth Hormone & IGF Research, 18, 111 135.
63. Ranke, M.B., Lindberg, A., Price, D.A. et al. (2007) Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Hormone Research, 68, 53 62.
64. Albertsson-Wikland, K., Aronson, A.S., Gustafsson, J. et al. (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism, 93, 4342 4350.
65. Guevara-Aguirre, J., Rosenbloom, A.L. Vasconez, O. (1997) Two-year treatment of growth hormone (GH) receptor deficiency (GHRD) with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. Journal of Clinical Endocrinology & Metabolism, 82, 629 633.
66. Ranke, M.B., Savage, M.O., Chatelain, P.G. et al. (1999) Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Hormone Research, 51, 128 134.
67. Chernausek, S.D., Backeljauw, P.F., Frane, J. et al. (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. Journal of Clinical Endocrinology & Metabolism, 92, 902 910.
68. Midyett, L.K., Rogol, A.D., Frane, J. et al. (2009) Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomised clinical trial. Journal of Clinical Endocrinology & Metabolism, 94, 3913 3921.
69. Janssen, J.A. (2009) Advantages and disadvantages of GH/IGF-I combination treatment. Reviews in Endocrine & Metabolic Disorders, 10, 157 162.
70. Midyett, L.K., Reiner, B., Rogol, A.D., et al. (2009) Preliminary results of a phase II, randomized, open-label, active-treatment controlled trial of rhGH & rhIGF-1 combination therapy in prepubertal children with nonsevere primary IGF-1 deficiency. 8th Joint, LWPES/Congress, ESPE & York, New, Abstract FC10-006.